Thrombocytopenia is common in hepatocellular carcinoma and may increase bleeding risk during antiangiogenic therapy, yet the clinically relevant platelet threshold remains uncertain. We found that a baseline platelet count < 50 × 109/L was associated with bleeding; patients below this cutoff had a substantially higher bleeding rate than those with ...
Jun Tie +8 more
wiley +1 more source
Preclinical Efficacy of a Hemostatic Agent in Overcoming Dual Antiplatelet Therapy. [PDF]
Efimenko E +5 more
europepmc +1 more source
Therapeutic use of α2-antiplasmin as an antifibrinolytic and hemostatic agent in surgery and regenerative medicine. [PDF]
Liu J +4 more
europepmc +1 more source
In Vitro and In Vivo Evaluation of the Biocompatibility and Cytotoxicity of Local Hemostatic Agents
Y Tomizawa +5 more
openalex +2 more sources
We systematically summarize how each scale dictates fundamental choices in design feature, manufacturing technology, driving mechanism, and control strategy, which are inherently governed by scale‐dominated physical principles. Furthermore, the application of scale‐determined operation modes of microrobots across different stages of medical ...
Hang Yin +3 more
wiley +1 more source
Medical management of intraluminal inferior vena cava thrombus from hemostatic agent after extreme lateral interbody fusion. [PDF]
Pak A, Stehlik K, Smith J, Petrinec D.
europepmc +1 more source
Comparison of the Algan Hemostatic Agent with Floseal in Rat Liver Laceration Bleeding Model. [PDF]
Binnetoğlu K +3 more
europepmc +1 more source
Biomarkers to predict outcomes in diabetic foot ulcers
Studies attempting to predict the healing outcome of diabetic foot ulcers (DFUs) have investigated various biological materials and recovered molecules that may aid in discriminating wounds that will heal and those that will not heal. This graphical abstract captures the commonly studied classes of biomarkers in the context of DFUs.
Julie Okiro +6 more
wiley +1 more source
Comment on "Propensity score-matched analysis comparing drains and no-drains in rectal cancer surgery: the value of using a hemostatic agent instead". [PDF]
Sun YH, Cai WR, Zou KJ.
europepmc +1 more source

